Our Mission
The HPTN develops and evaluates cutting-edge biomedical, behavioral, and structural interventions to reduce the transmission of HIV.
Innovative, transformative, and impactful
24
Active Studies
55
Study Sites
13
Countries
582
Publications
Our Research Agenda
The HPTN research agenda focuses on four strategies:
- Long-acting antiretroviral (ARV) agents for pre-exposure prophylaxis (PrEP)
- Multipurpose prevention technologies (MPTs)
- Broadly neutralizing antibodies (bnAbs)
- Integrated strategies for HIV prevention
Powered by Collaboration
Join us at the 2026 HPTN Annual Meeting
Online and at the Crystal Gateway Marriott in Arlington, Virginia, USA, this hybrid meeting will bring together researchers, community partners, and stakeholders from around the globe to engage in meaningful discussions regarding the Network’s scientific agenda, highlight current studies, and collaborate on future HIV prevention research priorities.
Learn more
Mentoring the Next Era of Researchers
HPTN Scholars Program
The HPTN Scholars Program seeks to provide scholar recipients with the knowledge, skills, and connections to further their careers as independent investigators in the HIV prevention research field.
Learn More